Evaluation of Disease Severity Using CSF Biomarkers in Patients With Probable Cerebral Amyloid Angiopathy.

Beaufort Q, Charbonnier C, Ruellan P, Ozkul-Wermester O, Amar V, Turpin D, Quillard-Muraine M, Gerardin E, Dufour D, Charidimou A, Balageas AC, Boulouis G, Pasi M, Wallon D, Grangeon L.